Medicare Enrolled
Dr. Shahrad Aynehchi, MD
Urology Physician · Whittier, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Aynehchi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aynehchi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aynehchi
Dr. Shahrad Aynehchi is an urology physician in Whittier, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Aynehchi performed 3,818 Medicare services across 1,639 unique beneficiaries.
Between the years covered by Open Payments, Dr. Aynehchi received a total of $5,238 from 52 pharmaceutical and/or device companies across 222 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aynehchi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 22% volume in CA
$5,238 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,818
Medicare services
Top 22% in CA for urology physician
1,639
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~191 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Leuprolide injectable, camcevi, 1 mg | 756 | $67 | $99 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
567 | $50 | $300 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
556 | $9 | $60 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
517 | $100 | $600 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
207 | $40 | $240 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
190 | $3 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
158 | $67 | $440 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
120 | $61 | $333 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
116 | $100 | $605 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
100 | $123 | $780 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
85 | $38 | $295 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
59 | $47 | $170 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
52 | $212 | $1,218 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
48 | $0 | $2 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
41 | $115 | $630 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
29 | $6 | $37 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
29 | $30 | $166 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
27 | $319 | $1,414 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
24 | $126 | $730 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
24 | $12 | $80 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
21 | $132 | $849 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
19 | $50 | $310 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
19 | $109 | $580 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
18 | $27 | $180 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
13 | $61 | $385 |
| Injection, garamycin, gentamicin, up to 80 mg | 12 | $2 | $12 |
| New patient office visit, complex (60-74 min) | 11 | $188 | $1,020 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,238
Total received (2018-2024)
Avg $748/year across 7 years
Top 32% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
222
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,944 (94.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$293 (5.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,130
2023
$1,298
2022
$1,004
2021
$447
2020
$205
2019
$574
2018
$579
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$210
Teleflex LLC
$171
Dendreon Pharmaceuticals LLC
$138
SUN PHARMACEUTICAL INDUSTRIES INC.
$94
ACCORD HEALTHCARE, INC.
$67
Janssen Biotech, Inc.
$53
Merck Sharp & Dohme LLC
$47
PFIZER INC.
$45
PROGENICS PHARMACEUTICALS, INC.
$35
UROGEN PHARMA, INC.
$35
ABBVIE INC.
$33
Myriad Genetic Laboratories, Inc.
$32
Tolmar, Inc.
$31
Alexion Pharmaceuticals, Inc.
$30
AstraZeneca Pharmaceuticals LP
$28
Bayer Healthcare Pharmaceuticals Inc.
$24
Telix Pharmaceuticals
$22
Cook Medical LLC
$20
Photocure Inc
$15
Top 3 companies account for 46.0% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$798
PFIZER INC.
$411
Sumitomo Pharma America, Inc.
$408
Teleflex LLC
$401
Dendreon Pharmaceuticals LLC
$369
Janssen Biotech, Inc.
$311
Merck Sharp & Dohme LLC
$240
Myriad Genetic Laboratories, Inc.
$201
Axonics, Inc.
$149
PROCEPT BioRobotics Corporation
$142
AbbVie Inc.
$124
AbbVie, Inc.
$112
Progenics Pharmaceuticals, Inc.
$112
ABBVIE INC.
$103
SUN PHARMACEUTICAL INDUSTRIES INC.
$94
Endo Pharmaceuticals Inc.
$93
ACCORD HEALTHCARE, INC.
$90
Boston Scientific Corporation
$65
Photocure Inc
$63
AstraZeneca Pharmaceuticals LP
$56
Coloplast Corp
$52
Alexion Pharmaceuticals, Inc.
$50
Blue Earth Diagnostics Limited
$50
Avadel Specialty Pharmaceuticals, LLC
$49
COLOPLAST CORP
$42
UROVANT SCIENCES INC
$38
PALETTE LIFE SCIENCES, INC.
$38
Ethicon US, LLC
$36
PROGENICS PHARMACEUTICALS, INC.
$35
UROGEN PHARMA, INC.
$35
Metuchen Pharmaceuticals
$32
Tolmar, Inc.
$31
FUJIFILM Healthcare Americas Corporation
$30
Antares Pharma, Inc.
$25
Palette Life Sciences, Inc.
$25
Ferring Pharmaceuticals Inc.
$24
Bayer Healthcare Pharmaceuticals Inc.
$24
Retrophin, Inc.
$24
Verity Pharmaceuticals Inc.
$24
Accord Healthcare, Inc.
$23
180 Medical, Inc.
$22
Curium US LLC
$22
Telix Pharmaceuticals
$22
Bayer HealthCare Pharmaceuticals Inc.
$21
Cook Medical LLC
$20
Medtronic USA, Inc.
$18
TOLMAR Pharmaceuticals, Inc.
$17
C. R. Bard, Inc. & Subsidiaries
$16
Becton, Dickinson and Company
$15
AngioDynamics, Inc.
$14
DENTSPLY IH Inc.
$13
Hollister Incorporated
$12
Top 3 companies account for 30.9% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AMS · AQUABEAM ROBOTIC SYSTEM · ARIETTA PRECISION · AVEED · Axonics · Axumin · Bard Urinary Drainage Bag · CAMCEVI · CYSVIEW · Cysview · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL BPH · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · LCS · LITHO 150 · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · Lupron Depot · MYRBETRIQ · NANOKNIFE · NOCDURNA · Noctiva · Nubeqa · ONLI · ORGOVYX · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Rezum Generator · SOLESTA · SPEEDICATH · STRATAFIX · SUTENT · SpeediCath · Stendra · TOVIAZ · Titan · Trelstar · ULTOMIRIS · UROLIFT · UroLift System · VESICARE · XIAFLEX · XTANDI · XYOSTED · YONSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
403
Per 100K population
4.1
County median income
$87,760
Nearest hospital
WHITTIER HOSPITAL MEDICAL CENTER
1.7 mi
1.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Aynehchi is a clinical cardiology specialist, with above-average Medicare volume (top 22% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Aynehchi experienced with leuprolide injectable, camcevi, 1 mg?
Based on Medicare claims data, Dr. Aynehchi performed 756 leuprolide injectable, camcevi, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aynehchi receive payments from pharmaceutical companies?
Yes. Dr. Aynehchi received a total of $5,238 from 52 companies across 222 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aynehchi's costs compare to other urology physicians in Whittier?
Dr. Aynehchi's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aynehchi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Whittier
Browse urology physicians in Whittier ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology